These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24308959)

  • 21. Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01.
    Fomsgaard A; Karlsson I; Gram G; Schou C; Tang S; Bang P; Kromann I; Andersen P; Andreasen LV
    Vaccine; 2011 Sep; 29(40):7067-74. PubMed ID: 21767590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.
    Snyder JT; Belyakov IM; Dzutsev A; Lemonnier F; Berzofsky JA
    J Virol; 2004 Jul; 78(13):7052-60. PubMed ID: 15194781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif.
    Lipford GB; Hoffman M; Wagner H; Heeg K
    J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
    Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
    Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope.
    Rudra JS; Mishra S; Chong AS; Mitchell RA; Nardin EH; Nussenzweig V; Collier JH
    Biomaterials; 2012 Sep; 33(27):6476-84. PubMed ID: 22695068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of antigen-specific CD4
    Weilhammer D; Dunkle AD; Blanchette CD; Fischer NO; Corzett M; Lehmann D; Boone T; Hoeprich P; Driks A; Rasley A
    Vaccine; 2017 Mar; 35(11):1475-1481. PubMed ID: 28214044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of a CD8+ cytotoxic T lymphocyte response to soluble antigen given together with a novel muramyl dipeptide adjuvant, N-acetyl-D-glucosaminyl-(beta 1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine (GMDP).
    Hornung RL; Longo DL; Gowda VL; Kwak LW
    Ther Immunol; 1995 Feb; 2(1):7-14. PubMed ID: 7553072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
    Meraldi V; Romero JF; Kensil C; Corradin G
    Vaccine; 2005 Apr; 23(21):2801-12. PubMed ID: 15780728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles.
    Stano A; Scott EA; Dane KY; Swartz MA; Hubbell JA
    Biomaterials; 2013 Jun; 34(17):4339-46. PubMed ID: 23478034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo.
    Serre K; Giraudo L; Siret C; Leserman L; Machy P
    Eur J Immunol; 2006 Jun; 36(6):1386-97. PubMed ID: 16673447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
    Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
    Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo.
    Powell TJ; Palath N; DeRome ME; Tang J; Jacobs A; Boyd JG
    Vaccine; 2011 Jan; 29(3):558-69. PubMed ID: 20951665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of vaccine-induced primary and memory CD8(+) T-cell responses by soluble PD-1.
    Song MY; Park SH; Nam HJ; Choi DH; Sung YC
    J Immunother; 2011 Apr; 34(3):297-306. PubMed ID: 21389868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
    Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
    Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization.
    Bristol JA; Orsini C; Lindinger P; Thalhamer J; Abrams SI
    Cell Immunol; 2000 Nov; 205(2):73-83. PubMed ID: 11104579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunodominant CD8 T cell response to the human cytomegalovirus tegument phosphoprotein pp65(495-503) epitope critically depends on CD4 T cell help in vaccinated HLA-A*0201 transgenic mice.
    Reiser M; Wieland A; Plachter B; Mertens T; Greiner J; Schirmbeck R
    J Immunol; 2011 Sep; 187(5):2172-80. PubMed ID: 21810614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biotin Functionalized Self-Assembled Peptide Nanofiber as an Adjuvant for Immunomodulatory Response.
    Demircan MB; Tohumeken S; Gunduz N; Khalily MA; Tekinay T; Guler MO; Tekinay AB
    Biotechnol J; 2020 Dec; 15(12):e2000100. PubMed ID: 32679620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulating adaptive immune responses to peptide self-assemblies.
    Rudra JS; Sun T; Bird KC; Daniels MD; Gasiorowski JZ; Chong AS; Collier JH
    ACS Nano; 2012 Feb; 6(2):1557-64. PubMed ID: 22273009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing the Magnitude of Antibody Responses through Biomaterial Stereochemistry.
    Appavu R; Chesson CB; Koyfman AY; Snook JD; Kohlhapp FJ; Zloza A; Rudra JS
    ACS Biomater Sci Eng; 2015 Jul; 1(7):601-609. PubMed ID: 33434976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers.
    Mora-Solano C; Wen Y; Han H; Chen J; Chong AS; Miller ML; Pompano RR; Collier JH
    Biomaterials; 2017 Dec; 149():1-11. PubMed ID: 28982051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.